RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Stock-based compensation

GILEAD SCIENCES, INC.GILD

Market cap
$155.4B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 2024835+9.01%
Dec 31, 2023766+20.25%
Dec 31, 2022637+0.31%
Dec 31, 2021635-1.24%
Dec 31, 2020643+1.10%
Dec 31, 2019636-24.73%
Dec 31, 2018845+32.45%
Dec 31, 2017638+67.89%
Dec 31, 2016380-0.52%
Dec 31, 2015382+6.11%
Dec 31, 2014360+42.87%
Dec 31, 2013252+20.73%
Dec 31, 2012209+8.50%
Dec 31, 2011192-3.83%
Dec 31, 2010200

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)